EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cyanobacterial Peptides in Anticancer Therapy: A Comprehensive Review of Mechanisms, Clinical Advances, and Biotechnological Innovation

Heayyean Lee iD, Khuld Nihan, Yale Ryan Kwon

Marine Drugs · 29.05.2025 · 23 (6) · 233

DOI: 10.3390/md23060233 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 29.05.2025. Verfasst von Heayyean Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Plamica Labs, Batten Hall, 125 Western Ave, Allston, MA 02163, USA. Hauptthemen laut MEDLINE: Cyanobacteria, Antineoplastic Agents, Peptides, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyanobacteria-derived peptides represent a promising class of anticancer agents due to their structural diversity and potent bioactivity. They exert cytotoxic effects through mechanisms including microtubule disruption, histone deacetylase inhibition, and apoptosis induction. Several peptides—most notably the dolastatin-derived auristatins—have achieved clinical success as cytotoxic payloads in antibody–drug conjugates (ADCs). However, challenges such as limited tumor selectivity, systemic toxicity, and production scalability remain barriers to broader application. Recent advances in targeted delivery technologies, combination therapy strategies, synthetic biology, and genome mining offer promising solutions. Emerging data from preclinical and clinical studies highlight their therapeutic potential, particularly in treatment-resistant cancers. In this review, we (i) summarize key cyanobacterial peptides and their molecular mechanisms of action, (ii) examine progress toward clinical translation, and (iii) explore biotechnological approaches enabling sustainable production and structural diversification. We also discuss future directions for enhancing specificity and the therapeutic index to fully exploit the potential of these marine-derived peptides in oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyanobacteriaAntineoplastic AgentsPeptidesNeoplasmsHumansBiotechnologyAnimals

Stichwörter der Autor:innen

antibody–drug conjugatesanticancercyanobacterial peptidescyclic peptidesdepsipeptidesheterologous expressionsynthetic biology

Substanzen

Antineoplastic AgentsPeptides

Autor:innen und Institutionen

  • Plamica Labs, Batten Hall, 125 Western Ave, Allston, MA 02163, USA.
  • Department of Medical School, Jinnah Sindh Medical University, Rafiqui H.J. Shaheed Road, Karachi 75510, Pakistan.

ORCID-Profile: Heayyean Lee

Zitieren

APA

Lee, H., Nihan, K., & Kwon, Y. R. (2025). Cyanobacterial Peptides in Anticancer Therapy: A Comprehensive Review of Mechanisms, Clinical Advances, and Biotechnological Innovation. Marine Drugs, 23(6), 233. https://doi.org/10.3390/md23060233

Vancouver

Lee H, Nihan K, Kwon YR. Cyanobacterial Peptides in Anticancer Therapy: A Comprehensive Review of Mechanisms, Clinical Advances, and Biotechnological Innovation. Marine Drugs. 2025;23(6):233. doi:10.3390/md23060233

BibTeX
@article{Lee2025,
  author = {Lee, Heayyean and Nihan, Khuld and Kwon, Yale Ryan},
  title = {Cyanobacterial Peptides in Anticancer Therapy: A Comprehensive Review of Mechanisms, Clinical Advances, and Biotechnological Innovation},
  journal = {Marine Drugs},
  year = {2025},
  volume = {23},
  number = {6},
  pages = {233},
  doi = {10.3390/md23060233}
}
Kostenlos starten →